Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy.
Sciarra A, Panebianco V, Ciccariello M, Salciccia S, Cattarino S, Lisi D, Gentilucci A, Alfarone A, Bernardo S, Passariello R, Gentile V. Sciarra A, et al. Among authors: cattarino s. Clin Cancer Res. 2010 Mar 15;16(6):1875-83. doi: 10.1158/1078-0432.CCR-09-2195. Epub 2010 Mar 2. Clin Cancer Res. 2010. PMID: 20197480 Clinical Trial.
Role of magnetic resonance spectroscopic imaging ([¹H]MRSI) and dynamic contrast-enhanced MRI (DCE-MRI) in identifying prostate cancer foci in patients with negative biopsy and high levels of prostate-specific antigen (PSA).
Panebianco V, Sciarra A, Ciccariello M, Lisi D, Bernardo S, Cattarino S, Gentile V, Passariello R. Panebianco V, et al. Among authors: cattarino s. Radiol Med. 2010 Dec;115(8):1314-29. doi: 10.1007/s11547-010-0575-3. Epub 2010 Sep 17. Radiol Med. 2010. PMID: 20852963 Clinical Trial. English, Italian.
Update on screening in prostate cancer based on recent clinical trials.
Sciarra A, Cattarino S, Gentilucci A, Salciccia S, Alfarone A, Mariotti G, Innocenzi M, Gentile V. Sciarra A, et al. Among authors: cattarino s. Rev Recent Clin Trials. 2011 Jan;6(1):7-15. doi: 10.2174/157488711793980165. Rev Recent Clin Trials. 2011. PMID: 20868347 Review.
Determination of the time for maximal response to neoadjuvant hormone therapy for prostate cancer using magnetic resonance with spectroscopy (MRSI) and dynamic contrast enhancement (DCEMR).
Sciarra A, Panebianco V, Salciccia S, Lisi D, Alfarone A, Gentilucci A, Parente U, Cattarino S, Passariello R, Gentile V. Sciarra A, et al. Among authors: cattarino s. Urol Oncol. 2012 Sep;30(5):614-9. doi: 10.1016/j.urolonc.2010.09.006. Epub 2011 Mar 10. Urol Oncol. 2012. PMID: 21396849 Clinical Trial.
[Role of neuroendocrine cells in prostate cancer progression].
Sciarra A, Innocenzi M, Ravaziol M, Minisola F, Alfarone A, Cattarino S, Panebianco V, Buonocore V, Gentile V, Di Silverio F. Sciarra A, et al. Among authors: cattarino s. Urologia. 2011 Apr-Jun;78(2):126-31. doi: 10.5301/RU.2011.8337. Urologia. 2011. PMID: 21574145 Italian.
59 results